DIN Registered Products: MI/MCI Mandatory Reporting

Posted April 11, 2016

By: Teri Dickinson, Regulatory Affairs Group Manager

Methylisothiazolinone/methylchloroisothiazolinone (MI/MCI), a preservative sometimes know as Kathon, is no longer permitted in any leave-on cosmetic products in Canada. Companies selling DIN Registered products must report the levels of MI/MCI to Health Canada EVEN IF THERE IS NO MI/MCI IN YOUR PRODUCT. Notification letters are due to Health Canada by April 18, 2016. Contact Dell Tech today if you require assistance submitting mandatory notifications to Health Canada by the due date.

DIN registered products include:

Pharmaceuticals
Sunscreen
Acne therapy products
Antiseptic skin cleansers
Anti-dandruff products
Athletes foot treatments,
Medicated skincare products
Diaper rash products
Throat lozenges
Disinfectants

Contact:
Dell Tech Laboratories
info@delltech.com
519-858-5021

Dell Tech has provided professional, confidential consulting services to the chemical specialty

industry in Canada, the USA, Europe, and Asia for the last 40 years.

Contact us today for more information.

www.delltech.com

acne therapy product, Anti-dandruff, antiseptic skin cleanser, Athletes foot treatment, Diaper rash product, DIN, disinfectant, Drug identification number, Medicated skincare product, Pharmaceuticals, sunscreen, Throat lozenge

Dell Tech